Literature DB >> 2107357

[2 year interferon therapy of metastatic carcinoid tumor].

W von Scheidt1, M Böhm, I Huber, R Habersetzer, K Jacob, A Markl, G Autenrieth.   

Abstract

A 39 year old male patient was treated with daily 5 X 10(6) IU interferon alpha 2b s.c. for 22 months because of advanced carcinoid tumor. Objective response was achieved with greater than 50% reduction of 5-HIAA-excretion. Multiple metastases (liver, lung, bones, thyroid gland) were not progressing in size. An unintentional omission of treatment resulted in a rapid biochemical and morphological tumor progression. Reversibility was achieved with reinstitution of effective interferon therapy. Thus, interferon therapy of advanced carcinoid tumor is able to induce a long-term objective response. It seems to be superior to conventional chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107357     DOI: 10.1007/bf01662725

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

1.  Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection.

Authors:  L M Itri; M Campion; R A Dennin; A V Palleroni; J U Gutterman; J E Groopman; P W Trown
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

2.  Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.

Authors:  J Soga; K Tazawa
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

3.  [Carcinoid syndrome with a course of more than 10 years].

Authors:  X Baur; A Bortsch; G Autenrieth; K Jacob; J Neudert; B Schneider; K Werdan
Journal:  Internist (Berl)       Date:  1988-05       Impact factor: 0.743

4.  Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.

Authors:  B Wiedenmann; U Räth; R Rädsch; F Becker; B Kommerell
Journal:  Klin Wochenschr       Date:  1988-01-15

Review 5.  The human interferons--from protein purification and sequence to cloning and expression in bacteria: before, between, and beyond.

Authors:  S Pestka
Journal:  Arch Biochem Biophys       Date:  1983-02-15       Impact factor: 4.013

6.  Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

Authors:  J R Quesada; A Rios; D Swanson; P Trown; J U Gutterman
Journal:  J Clin Oncol       Date:  1985-11       Impact factor: 44.544

7.  [Carcinoid tumor of the liver].

Authors:  H Ito; H Masuda; E Tahara; C Wittekind
Journal:  Dtsch Med Wochenschr       Date:  1989-04-21       Impact factor: 0.628

8.  Surgical treatment of functioning metastatic carcinoid tumors.

Authors:  J K Martin; C G Moertel; M A Adson; A J Schutt
Journal:  Arch Surg       Date:  1983-05

9.  [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].

Authors:  C Doberauer; N Niederle; O Kloke; E Kurschel; C G Schmidt
Journal:  Onkologie       Date:  1987-12

10.  The use of a long-acting somatostatin analogue in the treatment of advanced endocrine malignancies with gastrointestinal symptoms.

Authors:  H Ahlman; L E Tisell
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.